RandallA.HawkinsMD
Nuclear Medicine • San Francisco, CAProfessor, Radiology, University of California, San Francisco, School of Medicine
Dr. Hawkins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 Parnassus Ave
San Francisco, CA 94143Phone+1 415-353-1554Fax+1 415-353-8571
Education & Training
Los Angeles County-Harbor-UCLA Medical CenterFellowship, Nuclear Radiology, 1979 - 1981
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Radiology-Diagnostic, 1976 - 1979- University of Southern California/Los Angeles General Medical Center (USC/LA General)Internship, Internal Medicine, 1975 - 1976
University of California, Irvine, School of MedicineClass of 1975
Certifications & Licensure
CA State Medical License 1976 - 2019- American Board of Nuclear Medicine Nuclear Medicine
- American Board of Radiology Diagnostic Radiology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Effect of Low Frequency Ultrasound on Kidney Function Start of enrollment: 2014 Jan 28
Publications & Presentations
PubMed
- Anatomic patterns of relapse and progression following treatment with 131 I-MIBG in relapsed or refractory neuroblastoma.Rotem Fishel Ben Kenan, Alexei L. Polishchuk, Randall A. Hawkins, Steve Braunstein, Katherine K. Matthay
Pediatric Blood & Cancer. 2021-10-18 - 19 citations124I-MIBG PET/CT to Monitor Metastatic Disease in Children with Relapsed NeuroblastomaMariam Aboian, Shih-ying Huang, Miguel Hernandez-Pampaloni, Randall A. Hawkins, Henry F. VanBrocklin
Journal of Nuclear Medicine. 2021-01-01 - 11 citationsTechnical Note: Simplified and practical pretherapy tumor dosimetry - A feasibility study for 131 I-MIBG therapy of neuroblastoma using 124 I-MIBG PET/CT.Youngho Seo, Yoonsuk Huh, Shih-ying Huang, J. Miguel Hernandez‐Pampaloni, Randall A. Hawkins
Medical Physics. 2019-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
